Board of Visitors

Joseph T. Abdalla (’89 BSPharm)
Vice President, Market Access Solutions
TrialCard

George Abercrombie, MBA (’78 BSPharm)
President and CEO
Abercrombie Advisors LLC
Pharmaceutical and Biotechnology Strategy and Operations

Paul J. Atkins, PhD
Vice President of Operations
Oriel Therapeutics, a Novartis Company

Paul W. Bush, PharmD, MBA
Chief Pharmacy Officer
Duke University Hospital
Department of Pharmacy

James W. Crow
United Therapeutics, Inc.
Founder, President and Chief Operating Officer (Retired)

Marty DeBerardinis, PhD ’82

Fred Eshelman, PharmD (’72 BSPharm)

Neal Fowler, MBA ’88 (’84 BSPharm)
CEO
Liquidia Technologies and Envisia Therapeutics

Joe Graedon, MS
President
Graedon Enterprises, Inc.
The People’s Pharmacy

Mark Gregory
Ateb, Inc.
Pharmacist, Business Development

Donna Gutterman, PharmD, MBA
President
Onesta Inc.

Reg Hardy, MBA (’81 BSPharm)
President
Brickell Biotech, Inc.

Jimmy Jackson
Spoke Consulting, Inc.

M. Ross Johnson, PhD
Founder and Cochairman
Parion Sciences, Inc.

Martin D. Marciniak, MPP, PhD
GlaxoSmithKlein
Vice President
US Health Outcomes and Medical Policy

Douglas W. Mendenhall, PhD
dwm Consulting, LLC

David S. Moody (’73 BSPharm)
CEO
Mutual Drug Company

William “Whit” Moose (’60 BSPharm)
Past President, NCPA
Moose Drug Company

Louis A. Newsome (’77 BSPharm)
OptumRx/UnitedHealthcare
Pharmacy Program Executive-Southeast Region

John Uhrin (’76 BSPharm)
President & CBO
ProteoVec, Inc.

P. Kay Wagoner, PhD
Blackstone Life Sciences EIR
Immediate Past President and CEO Icagen, Inc.

Chris L. Waller, PhD ’92
Director and Head, Scientific Modeling Platforms
Merck Research Laboratories